The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Abstract
BACKGROUND: The prevalence of heart failure with preserved ejection fraction may be changing as a result of changes in population demographics and in the prevalence and treatment of risk factors for heart failure. Changes in the prevalence of heart failure with preserved ejection fraction may contribute to changes in the natural history of heart failure. We performed a study to define secular trends in the prevalence of heart failure with preserved ejection fraction among patients at a single institution over a 15-year period. METHODS: We studied all consecutive patients hospitalized with decompensated heart failure at Mayo Clinic Hospitals in Olmsted County, Minnesota, from 1987 through 2001. We classified patients as having either preserved or reduced ejection fraction. The patients were also classified as community patients (Olmsted County residents) or referral patients. Secular trends in the type of heart failure, associated cardiovascular disease, and survival were defined. RESULTS: A total of 6076 patients with heart failure were discharged over the 15-year period; data on ejection fraction were available for 4596 of these patients (76 percent). Of these, 53 percent had a reduced ejection fraction and 47 percent had a preserved ejection fraction. The proportion of patients with the diagnosis of heart failure with preserved ejection fraction increased over time and was significantly higher among community patients than among referral patients (55 percent vs. 45 percent). The prevalence rates of hypertension, atrial fibrillation, and diabetes among patients with heart failure increased significantly over time. Survival was slightly better among patients with preserved ejection fraction (adjusted hazard ratio for death, 0.96; P=0.01). Survival improved over time for those with reduced ejection fraction but not for those with preserved ejection fraction. CONCLUSIONS: The prevalence of heart failure with preserved ejection fraction increased over a 15-year period, while the rate of death from this disorder remained unchanged. These trends underscore the importance of this growing public health problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Self-citationHeart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Self-citation2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Self-citationHeart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Self-citationRosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Self-citationWRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
Self-citationSpironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
Epidemiology and risk profile of heart failure
Bui, A. L., Horwich, T. B., & Fonarow, G. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.165 · Cited by 2,077
“HF and preserved LVEF now represents >50% of HF cases and can have outcomes as poor as those associated with HF and reduced LVEF, but it does not yet have a proven effective management strategy”
BackgroundIrbesartan in patients with heart failure and preserved ejection fraction
Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805450 · Cited by 1,960
Clinical epidemiology of heart failure
Mosterd, A., & Hoes, A. W. (2007) · Heart · doi:10.1136/hrt.2003.025270 · Cited by 1,922
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Roger, V. L. (2013) · Circulation Research · doi:10.1161/circresaha.113.300268 · Cited by 1,728
Self-citationMedical Therapy for Heart Failure With Reduced Ejection Fraction
Greene, S. J., Butler, J., Albert, N. M., DeVore, A. D., Sharma, P. P., Duffy, C. I., Hill, C. L., McCague, K., Mi, X., Patterson, J. H., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.070 · Cited by 1,314
Young, T. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.8.893 · Cited by 1,304
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Shah, S. J., Katz, D. H., Selvaraj, S., Burke, M. A., Yancy, C. W., Gheorghiade, M., Bonow, R. O., Huang, C.-C., & Deo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.114.010637 · Cited by 1,157
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction
Shah, K. S., Xu, H., Matsouaka, R. A., Bhatt, D. L., Heidenreich, P. A., Hernandez, A. F., Devore, A. D., Yancy, C. W., & Fonarow, G. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.074 · Cited by 1,110
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
Chioncel, O., Lainscak, M., Seferovic, P. M., Anker, S. D., Crespo-Leiro, M. G., Harjola, V.-P., Parissis, J., Laroche, C., Piepoli, M. F., Fonseca, C., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.813 · Cited by 927
Kitzman, D. W., Brubaker, P., Morgan, T., Haykowsky, M., Hundley, G., Kraus, W. E., Eggebeen, J., & Nicklas, B. J. (2016) · JAMA · doi:10.1001/jama.2015.17346 · Cited by 921
Mohammed, S. F., Hussain, S., Mirzoyev, S. A., Edwards, W. D., Maleszewski, J. J., & Redfield, M. M. (2015) · Circulation · doi:10.1161/circulationaha.114.009625 · Cited by 874
Self-citationExercise-based rehabilitation for heart failure
Taylor, R. S., Sagar, V. A., Davies, E. J., Briscoe, S., Coats, A. J., Dalal, H., Lough, F., Rees, K., Singh, S. J., & Mordi, I. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003331.pub4 · Cited by 871
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Heart Failure With Preserved Ejection Fraction In Perspective
Pfeffer, M. A., Shah, A. M., & Borlaug, B. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.313572 · Cited by 837
The pathophysiology of heart failure with preserved ejection fraction
Borlaug, B. A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.83 · Cited by 726
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Epidemiology and clinical course of heart failure with preserved ejection fraction
Lam, C. S. P., Donal, E., Kraigher-Krainer, E., & Vasan, R. S. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq121 · Cited by 709
Zile, M. R., Baicu, C. F., S. Ikonomidis, J., Stroud, R. E., Nietert, P. J., Bradshaw, A. D., Slater, R., Palmer, B. M., Van Buren, P., Meyer, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013215 · Cited by 681
Heart Failure With Preserved Ejection Fraction: A Review
Redfield, M. M., & Borlaug, B. A. (2023) · JAMA · doi:10.1001/jama.2023.2020 · Cited by 662
Self-citationWestermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.931451 · Cited by 644
The Aging Cardiovascular System
Paneni, F., Diaz Cañestro, C., Libby, P., Lüscher, T. F., & Camici, G. G. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.064 · Cited by 618
Piché, M.-E., Poirier, P., Lemieux, I., & Després, J.-P. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.06.004 · Cited by 558
Tsao, C. W., Lyass, A., Enserro, D., Larson, M. G., Ho, J. E., Kizer, J. R., Gottdiener, J. S., Psaty, B. M., & Vasan, R. S. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.03.006 · Cited by 574
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
Seferović, P. M., & Paulus, W. J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv134 · Cited by 552
Kittleson, M. M., Panjrath, G. S., Amancherla, K., Davis, L. L., Deswal, A., Dixon, D. L., Januzzi, J. L., & Yancy, C. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.393 · Cited by 554
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
Mentz, R. J., Kelly, J. P., von Lueder, T. G., Voors, A. A., Lam, C. S. P., Cowie, M. R., Kjeldsen, K., Jankowska, E. A., Atar, D., Butler, J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.08.036 · Cited by 546
Heart Failure With Preserved Ejection Fraction: Mechanisms, Clinical Features, and Therapies
Sharma, K., & Kass, D. A. (2014) · Circulation Research · doi:10.1161/circresaha.115.302922 · Cited by 508
Mant, J., Doust, J., Roalfe, A., Barton, P., Cowie, M., Glasziou, P., Mant, D., McManus, R., Holder, R., Deeks, J., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13320 · Cited by 498
Shah, A. M., Claggett, B., Sweitzer, N. K., Shah, S. J., Anand, I. S., Liu, L., Pitt, B., Pfeffer, M. A., & Solomon, S. D. (2015) · Circulation · doi:10.1161/circulationaha.115.015884 · Cited by 478
Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction
Westermann, D., Kasner, M., Steendijk, P., Spillmann, F., Riad, A., Weitmann, K., Hoffmann, W., Poller, W., Pauschinger, M., Schultheiss, H.-P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.716886 · Cited by 474
Structured telephone support or non-invasive telemonitoring for patients with heart failure
Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., & Cleland, J. G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007228.pub3 · Cited by 453
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction
Cohen, J. B., Schrauben, S. J., Zhao, L., Basso, M. D., Cvijic, M. E., Li, Z., Yarde, M., Wang, Z., Bhattacharya, P. T., Chirinos, D. A., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.09.009 · Cited by 432
Relationship between physical activity, body mass index, and risk of heart failure
Pandey, A., LaMonte, M., Klein, L., Ayers, C., Psaty, B. M., Eaton, C. B., Allen, N. B., de Lemos, J. A., Carnethon, M., Greenland, P., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.081 · Cited by 398
Kitzman, D. W., Brubaker, P. H., Herrington, D. M., Morgan, T. M., Stewart, K. P., Hundley, W. G., Abdelhamed, A., & Haykowsky, M. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.033 · Cited by 369
Haykowsky, M. J., Brubaker, P. H., Stewart, K. P., Morgan, T. M., Eggebeen, J., & Kitzman, D. W. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.055 · Cited by 358
Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction
Ho, J. E., Lyass, A., Lee, D. S., Vasan, R. S., Kannel, W. B., Larson, M. G., & Levy, D. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.972828 · Cited by 343
Rossignol, P., Hernandez, A. F., Solomon, S. D., & Zannad, F. (2019) · The Lancet · doi:10.1016/s0140-6736(18)31808-7 · Cited by 316
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction
Hahn, V. S., Knutsdottir, H., Luo, X., Bedi, K., Margulies, K. B., Haldar, S. M., Stolina, M., Yin, J., Khakoo, A. Y., Vaishnav, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050498 · Cited by 291
Thenappan, T., Shah, S. J., Gomberg-Maitland, M., Collander, B., Vallakati, A., Shroff, P., & Rich, S. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.958801 · Cited by 289
Komajda, M., Hanon, O., Hochadel, M., Lopez-Sendon, J. L., Follath, F., Ponikowski, P., Harjola, V.-P., Drexler, H., Dickstein, K., Tavazzi, L., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn539 · Cited by 284
Metabolic inflammation in heart failure with preserved ejection fraction
Schiattarella, G. G., Rodolico, D., & Hill, J. A. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa217 · Cited by 284
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction
AbouEzzeddine, O. F., Davies, D. R., Scott, C. G., Fayyaz, A. U., Askew, J. W., McKie, P. M., Noseworthy, P. A., Johnson, G. B., Dunlay, S. M., Borlaug, B. A., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.3070 · Cited by 220
Self-citationPatel, V. B., Shah, S., Verma, S., & Oudit, G. Y. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9644-1 · Cited by 218
Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes
Lindman, B. R., Dávila-Román, V. G., Mann, D. L., McNulty, S., Semigran, M. J., Lewis, G. D., de las Fuentes, L., Joseph, S. M., Vader, J., Hernandez, A. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.030 · Cited by 209
Self-citationEggebeen, J., Kim-Shapiro, D. B., Haykowsky, M., Morgan, T. M., Basu, S., Brubaker, P., Rejeski, J., & Kitzman, D. W. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.12.013 · Cited by 190
“H eart failure with preserved ejection fraction (HFpEF) is the most common form of HF, is nearly unique to the older population, particularly older women, and is increasing in prevalence (1,2).”
Joseph, S. M., Novak, E., Arnold, S. V., Jones, P. G., Khattak, H., Platts, A. E., Dávila-Román, V. G., Mann, D. L., & Spertus, J. A. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000359 · Cited by 192
Hummel, S. L., Seymour, E. M., Brook, R. D., Sheth, S. S., Ghosh, E., Zhu, S., Weder, A. B., Kovács, S. J., & Kolias, T. J. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000481 · Cited by 190
Haykowsky, M. J., Brubaker, P. H., Morgan, T. M., Kritchevsky, S., Eggebeen, J., & Kitzman, D. W. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt011 · Cited by 189
Kolkhof, P., Jaisser, F., Kim, S.-Y., Filippatos, G., Nowack, C., & Pitt, B. (2016) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_76 · Cited by 180
Haykowsky, M. J., Nicklas, B. J., Brubaker, P. H., Hundley, W. G., Brinkley, T. E., Upadhya, B., Becton, J. T., Nelson, M. D., Chen, H., & Kitzman, D. W. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.06.002 · Cited by 179
Bowen, T. S., Rolim, N. P. L., Fischer, T., Bækkerud, F. H., Medeiros, A., Werner, S., Brønstad, E., Rognmo, O., Mangner, N., Linke, A., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.239 · Cited by 165
Hummel, S. L., Seymour, E. M., Brook, R. D., Kolias, T. J., Sheth, S. S., Rosenblum, H. R., Wells, J. M., & Weder, A. B. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.202705 · Cited by 161
Association of glucose metabolism with diastolic function along the diabetic continuum
Stahrenberg, R., Edelmann, F., Mende, M., Kockskämper, A., Düngen, H. D., Scherer, M., Kochen, M. M., Binder, L., Herrmann-Lingen, C., Gelbrich, G., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1718-8 · Cited by 141
Heart failure: when form fails to follow function
Katz, A. M., & Rolett, E. L. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv548 · Cited by 141
Understanding heart failure; explaining telehealth—a hermeneutic systematic review
Greenhalgh, T., A’Court, C., & Shaw, S. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0594-2 · Cited by 141
Patient selection in heart failure with preserved ejection fraction clinical trials
Kelly, J. P., Mentz, R. J., Mebazaa, A., Voors, A. A., Butler, J., Roessig, L., Fiuzat, M., Zannad, F., Pitt, B., O’Connor, C. M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.043 · Cited by 139
Evaluation of left ventricular diastolic function with cardiac MR imaging.
Caudron, J., Fares, J., Bauer, F., & Dacher, J.-N. (2011) · Radiographics · doi:10.1148/rg.311105049 · Cited by 129
Kanagala, P., Cheng, A. S. H., Singh, A., Khan, J. N., Gulsin, G. S., Patel, P., Gupta, P., Arnold, J. R., Squire, I. B., Ng, L. L., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.11.031 · Cited by 126
Dauriz, M., Mantovani, A., Bonapace, S., Verlato, G., Zoppini, G., Bonora, E., & Targher, G. (2017) · Diabetes Care · doi:10.2337/dc17-0697 · Cited by 123
Mikhalkova, D., Holman, S. R., Jiang, H., Saghir, M., Novak, E., Coggan, A. R., O'Connor, R., Bashir, A., Jamal, A., Ory, D. S., et al. (2018) · Obesity · doi:10.1002/oby.22038 · Cited by 121
Jeong, E., Chung, J., Liu, H., Go, Y., Gladstein, S., Farzaneh‐Far, A., Lewandowski, E. D., & Dudley, S. C. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003046 · Cited by 119
Upadhya, B., Rocco, M., Lewis, C. E., Oparil, S., Lovato, L. C., Cushman, W. C., Bates, J. T., Bello, N. A., Aurigemma, G., Fine, L. J., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003613 · Cited by 118
Bates, B. A., Akhabue, E., Nahass, M. M., Mukherjee, A., Hiltner, E., Rock, J., Wilton, B., Mittal, G., Visaria, A., Rua, M., et al. (2023) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.122.009078 · Cited by 118
Beale, A. L., Warren, J. L., Roberts, N., Meyer, P., Townsend, N. P., & Kaye, D. (2019) · Open Heart · doi:10.1136/openhrt-2019-001012 · Cited by 112
Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function
Rosas, P. C., Liu, Y., Abdalla, M. I., Thomas, C. M., Kidwell, D. T., Dusio, G. F., Mukhopadhyay, D., Kumar, R., Baker, K. M., Mitchell, B. M., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001550 · Cited by 112
Alehagen, U., Benson, L., Edner, M., Dahlström, U., & Lund, L. H. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002143 · Cited by 109
Artificial Intelligence-Enabled ECG for Left Ventricular Diastolic Function and Filling Pressure
Lee, E., Ito, S., Miranda, W. R., Lopez-Jimenez, F., Kane, G. C., Asirvatham, S. J., Noseworthy, P. A., Friedman, P. A., Carter, R. E., Borlaug, B. A., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-023-00993-7 · Cited by 106
Shafiq, A., Brawner, C. A., Aldred, H. A., Lewis, B., Williams, C. T., Tita, C., Schairer, J. R., Ehrman, J. K., Velez, M., Selektor, Y., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2015.12.020 · Cited by 102
Impact of obstructive sleep apnoea on diastolic function
Wachter, R., Lüthje, L., Klemmstein, D., Lüers, C., Stahrenberg, R., Edelmann, F., Holzendorf, V., Hasenfuß, G., Andreas, S., & Pieske, B. (2013) · European Respiratory Journal · doi:10.1183/09031936.00218211 · Cited by 93
Kwon, J.-M., Kim, K.-H., Eisen, H. J., Cho, Y., Jeon, K.-H., Lee, S. Y., Park, J., & Oh, B.-H. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztaa015 · Cited by 82
Risk factors and interventions with statistically significant tiny effects
Siontis, G. C., & Ioannidis, J. P. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr099 · Cited by 80
Lindman, B. R., Pibarot, P., Arnold, S. V., Suri, R. M., McAndrew, T. C., Maniar, H. S., Zajarias, A., Kodali, S., Kirtane, A. J., Thourani, V. H., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.057 · Cited by 75
Kodama*, S., Fujihara, K., Horikawa, C., Sato, T., Iwanaga, M., Yamada, T., Kato, K., Watanabe, K., Shimano, H., Izumi, T., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12782 · Cited by 63
Targeting obesity and diabetes to treat heart failure with preserved ejection fraction
Altara, R., Giordano, M., Nordén, E. S., Cataliotti, A., Kurdi, M., Bajestani, S. N., & Booz, G. W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00160 · Cited by 61
Hullon, D., Subeh, G. K., Volkova, Y., Janiec, K., Trach, A., & Mnevets, R. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02607-w · Cited by 59
Bielecka-Dabrowa, A., Bytyçi, I., Von Haehling, S., Anker, S., Jozwiak, J., Rysz, J., Hernandez, A. V., Bajraktari, G., Mikhalidis, D. P., & Banach, M. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1135-z · Cited by 57
Community Care in England: Reducing Socioeconomic Inequalities in Heart Failure
Hawkins, N. M., Scholes, S., Bajekal, M., Love, H., O'Flaherty, M., Raine, R., & Capewell, S. (2012) · Circulation · doi:10.1161/circulationaha.111.088047 · Cited by 52
Makam, A. N., & Nguyen, O. K. (2017) · Circulation · doi:10.1161/circulationaha.116.022622 · Cited by 52
Mathew, A. V., Seymour, E. M., Byun, J., Pennathur, S., & Hummel, S. L. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.10.003 · Cited by 48
Li, C., Zhang, J., Zhou, C., Huang, L., Tang, H., & Rao, L. (2010) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep218 · Cited by 42
Cocco, G., & Pandolfi, S. (2011) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00380.x · Cited by 32
Metadata
- Authors
- Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-07-20
- Volume
- 355
- Issue
- 3
- Pages
- 251-259
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2137784332
- Cited by
- 4,191
- References
- 3
- FWCI
- 101.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.